JP2020536892A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020536892A5 JP2020536892A5 JP2020520112A JP2020520112A JP2020536892A5 JP 2020536892 A5 JP2020536892 A5 JP 2020536892A5 JP 2020520112 A JP2020520112 A JP 2020520112A JP 2020520112 A JP2020520112 A JP 2020520112A JP 2020536892 A5 JP2020536892 A5 JP 2020536892A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- activator
- composition according
- hours
- paddle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023090883A JP2023123471A (ja) | 2017-10-09 | 2023-06-01 | 医薬レジネート組成物、それを作製する方法、およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762569813P | 2017-10-09 | 2017-10-09 | |
| US62/569,813 | 2017-10-09 | ||
| PCT/US2018/054830 WO2019074829A1 (en) | 2017-10-09 | 2018-10-08 | RESINATE-BASED PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEM |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023090883A Division JP2023123471A (ja) | 2017-10-09 | 2023-06-01 | 医薬レジネート組成物、それを作製する方法、およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020536892A JP2020536892A (ja) | 2020-12-17 |
| JP2020536892A5 true JP2020536892A5 (https=) | 2021-11-18 |
Family
ID=66100936
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020520112A Withdrawn JP2020536892A (ja) | 2017-10-09 | 2018-10-08 | 医薬レジネート組成物、それを作製する方法、およびその使用 |
| JP2023090883A Pending JP2023123471A (ja) | 2017-10-09 | 2023-06-01 | 医薬レジネート組成物、それを作製する方法、およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023090883A Pending JP2023123471A (ja) | 2017-10-09 | 2023-06-01 | 医薬レジネート組成物、それを作製する方法、およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11690840B2 (https=) |
| EP (1) | EP3694555A4 (https=) |
| JP (2) | JP2020536892A (https=) |
| KR (1) | KR102901919B1 (https=) |
| CN (2) | CN119524126A (https=) |
| AU (3) | AU2018347991A1 (https=) |
| CA (1) | CA3078844A1 (https=) |
| IL (2) | IL273904B2 (https=) |
| WO (1) | WO2019074829A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102881925B1 (ko) * | 2022-02-22 | 2025-11-06 | 인제대학교 산학협력단 | 양이온교환수지를 사용한 약물의 방출 조절을 위한 조성물 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1086226A (en) * | 1976-11-26 | 1980-09-23 | Yegnaswami Raghunathan | Ion exchange resin prolonged release pharmaceutical preparations |
| US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
| CA2379987A1 (en) * | 1999-07-29 | 2001-02-08 | Roxane Laboratories, Inc. | Opioid sustained-released formulation |
| US20030118641A1 (en) * | 2000-07-27 | 2003-06-26 | Roxane Laboratories, Inc. | Abuse-resistant sustained-release opioid formulation |
| KR100889069B1 (ko) | 1999-10-29 | 2009-03-17 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
| HU229705B1 (en) | 2000-02-08 | 2014-05-28 | Euro Celtique Sa | Tamper-resistant oral opioid agonist formulations |
| AR039744A1 (es) | 2002-06-26 | 2005-03-09 | Alza Corp | Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada |
| US8343546B2 (en) * | 2005-09-13 | 2013-01-01 | Coating Place, Inc. | Ion exchange resin treated to control swelling |
| CA2645855C (en) * | 2006-03-16 | 2015-02-03 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| CA2689101C (en) | 2007-05-30 | 2013-01-22 | Neos Therapeutics, Lp | Modifying drug release in suspensions of ionic resin systems |
| JP5482012B2 (ja) * | 2008-09-19 | 2014-04-23 | セイコーエプソン株式会社 | ターゲット支持装置、ターゲット搬送機構及び液体噴射装置 |
| WO2011063164A2 (en) * | 2009-11-18 | 2011-05-26 | Steady Sleep Rx Co., Inc. | Sustained release cannabinoid medicaments |
| WO2011107855A2 (en) * | 2010-03-04 | 2011-09-09 | Torrent Pharmaceuticals Limited | Sustained release oral liquid suspension dosage form |
| US8623409B1 (en) * | 2010-10-20 | 2014-01-07 | Tris Pharma Inc. | Clonidine formulation |
| US20130230587A1 (en) * | 2010-11-10 | 2013-09-05 | Rubicon Research Private Limited | Sustained release compositions |
| KR20180027641A (ko) * | 2011-02-02 | 2018-03-14 | 알파마 파머슈티컬스 엘엘씨 | 오피오이드 효능제 및 격리된 길항제를 포함하는 제약 조성물 |
| WO2013003845A1 (en) | 2011-06-30 | 2013-01-03 | Neos Therapeutics, Lp | Abuse resistant drug forms |
| WO2013119231A1 (en) | 2012-02-09 | 2013-08-15 | Tris Pharma, Inc. | Abuse resistant opioid drug - ion exchange resin complexes having hybrid coatings |
| CN109820830A (zh) | 2012-03-02 | 2019-05-31 | 罗德兹制药股份有限公司 | 抗破坏性立即释放型制剂类 |
| KR102290178B1 (ko) * | 2013-03-13 | 2021-08-18 | 트리스 파마 인코포레이티드 | 벤조나테이트 변형 방출 고체 정제 및 캡슐 |
| MA41152A (fr) | 2014-12-12 | 2017-10-17 | Johnson & Johnson Consumer Inc | Procédé de fabrication de particules de résinate de phényléphrine ; particules de résinate de phényléphrine et utilisation des particules de résinate de phényléphrine dans des formulations pharmaceutiques |
| WO2018071381A1 (en) * | 2016-10-10 | 2018-04-19 | Rhodes Pharmaceuticals L.P. | Pharmaceutical resinate compositions and methods of making and using thereof |
-
2018
- 2018-10-08 AU AU2018347991A patent/AU2018347991A1/en not_active Abandoned
- 2018-10-08 US US16/754,940 patent/US11690840B2/en active Active
- 2018-10-08 WO PCT/US2018/054830 patent/WO2019074829A1/en not_active Ceased
- 2018-10-08 IL IL273904A patent/IL273904B2/en unknown
- 2018-10-08 JP JP2020520112A patent/JP2020536892A/ja not_active Withdrawn
- 2018-10-08 KR KR1020207012585A patent/KR102901919B1/ko active Active
- 2018-10-08 CN CN202410622045.6A patent/CN119524126A/zh active Pending
- 2018-10-08 IL IL311303A patent/IL311303B1/en unknown
- 2018-10-08 CN CN201880078034.9A patent/CN111629758A/zh active Pending
- 2018-10-08 EP EP18866039.3A patent/EP3694555A4/en active Pending
- 2018-10-08 CA CA3078844A patent/CA3078844A1/en active Pending
-
2022
- 2022-03-16 AU AU2022201848A patent/AU2022201848B2/en active Active
-
2023
- 2023-05-19 US US18/199,475 patent/US20230285388A1/en not_active Abandoned
- 2023-06-01 JP JP2023090883A patent/JP2023123471A/ja active Pending
-
2024
- 2024-09-05 AU AU2024219439A patent/AU2024219439A1/en active Pending
-
2025
- 2025-08-13 US US19/298,851 patent/US20250375438A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8987291B2 (en) | Opioid-containing oral pharmaceutical compositions and methods | |
| JP2015044834A5 (https=) | ||
| AU2011271429B2 (en) | Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid | |
| RU2000101024A (ru) | Опоидные анальгетики с контролируемым высвобождением активных веществ | |
| JP2005247859A5 (https=) | ||
| JP2015511953A5 (https=) | ||
| JP2014510094A5 (https=) | ||
| HRP20120641T1 (hr) | Oralni farmaceutski oblici doziranja otporni na neovlašteno korištenje koji sadrže opioidni analgetik | |
| JP2018012711A5 (https=) | ||
| CA2547334A1 (en) | Methods and compositions for deterring abuse of opioid containing dosage forms | |
| JP2011137020A5 (https=) | ||
| HRP20150835T1 (hr) | Farmaceutski oblici doziranja s kontroliranim oslobađanjem | |
| JP2004515455A5 (https=) | ||
| JP2015500273A5 (https=) | ||
| JP2010511683A5 (https=) | ||
| JP2016014040A5 (https=) | ||
| WO2008045556A2 (en) | Novel synergistic opioid-cannabinoid codrug for pain management | |
| WO2020055725A4 (en) | Dopamine d3 receptor selective antagonists/partial agonists and uses thereof | |
| CN105120846A (zh) | 抗篡改的药物制剂 | |
| JP2014530185A5 (https=) | ||
| JP2018080197A (ja) | オピオイド誘発性有害薬力学的応答を治療するためのシステムおよび方法 | |
| KR102720795B1 (ko) | 중수소화 덱스트로메토르판의 합성 방법 | |
| JP2020536892A5 (https=) | ||
| JP2017526719A5 (https=) | ||
| IL273904B2 (en) | Medicinal resin components and methods for their production and use |